Background: Type I diabetes is a global public health concern that affects young people of reproductive age and can damage oocytes, reducing their maturation rate and blocking embryonic development. Understanding the effects of type I diabetes on oocytes is important to facilitate the maintenance of reproductive capacity in female diabetic patients. Methods: To analyze the effects of type I diabetes on mammalian oocytes, protein profile changes in mice with streptozotocin-induced type I diabetes were investigated using proteomic tools; nondiabetic mouse oocytes were used as controls. Immunofluorescence analysis for the spindle and mitochondria of oocytes. Results: We found that type I diabetes severely disturbed the metabolic processes of mouse oocytes. We also observed significant changes in levels of histone H1, H2A/B, and H3 variants in diabetic oocytes (fold change: > 0.4 or < -0.4), with the potential to block activation of the zygotic genome and affect early embryo development. Furthermore, diabetic oocytes exhibited higher abnormal spindle formation and spatial remodeling of mitochondria than observed in the controls. Conclusion: Our results indicate that type I diabetes disrupts metabolic processes, spindle formation, mitochondria distribution and modulates epigenetic code in oocytes. Such effects could have a major impact on the reproductive dynamics of female patients with type I diabetes.
Effect of Type I Diabetes on the Proteome of Mouse Oocytes

Introduction
Gestational diabetes mellitus (GDM) is a risk factor for pregnancy-related maternal and fetal morbidity [1] . Previous studies have shown that type I diabetes can severely decrease mammalian oocyte quality. Diabetic mouse oocytes contain more mitochondrial DNA and exhibit greater transcription of mitochondrial genes than non-diabetic mouse oocytes [2] , and oocyte maturation and ovulation rates are considerably lower than those of controls [3] . Ovulated oocytes from diabetic mice can be fertilized; however, the majority of embryos from diabetic mice cannot develop to the blastocyst stage [4] . A recent report demonstrated that type I diabetes can alter the expression of DNMT1, which is associated with DNA methylation [5] , another study showed that certain lncRNAs might play a role in GDM macrosomia development [6] . This indicates that GDM may influence epigenetic modification in mouse oocytes. Epigenetics provides a link between environmental factors that have been linked to poor pregnancy outcomes and fetal quality [7] .
Most maternal mRNAs that accumulate in oocytes have short poly(A) tails and are not translated until the early embryo stage [8] ; therefore, transcriptome analysis of type I diabetic oocytes does not reflect actual protein levels, or even mRNA levels, as the poly(A) tail length affects the cDNA synthesis rate. Therefore, we used a streptozotocin (STZ)-induced mouse model for proteomic profiling of diabetic mouse oocytes and to characterize how type I diabetes affects mammalian oocyte quality. Elucidation of the landscape of protein modulation in type I diabetic oocytes may facilitate efforts to ameliorate the reproductive defects observed in this disease.
Materials and Methods
Establishment of a Type I diabetes mouse model and oocyte isolation
All experimental protocols were performed in accordance with relevant guidelines and regulations and approved by Beijing University of Chinese Medicine, China. ICR female mice (6-7 weeks old) were used for our experiments. The type I diabetes mouse model was established by intraperitoneal injection of STZ as described by Bonnevie-Nielsen [9] . Four days after STZ (STZ-Na-citrate solution) injection, glucose concentrations were measured in tail blood samples using an Accu-CHEK active glucometer (Roche Diagnostics). Mice with glucose levels > 16.7 mmol/L (n = 72) were selected as diabetic model animals. Control mice (n = 66) were injected with an equivalent volume of Na-citrate solution and their blood sugar level was checked to ensure that it was < 8.4 mmol/L. Diabetic mice and age-matched controls were injected intraperitoneally with 10 IU of pregnant mare serum gonadotropin (PMSG) for ovarian follicle stimulation. After 48 h, 10 IU of human chorionic gonadotropin (hCG) was injected to induce superovulation. Cumulus oocyte complexes (COCs) were isolated from diabetic and control mice 14 h after hCG injection. COCs were treated with 1 mg/mL hyaluronidase, and metaphase II (MII)-stage oocytes were isolated, We showed the above protocol by visual representation [10] (Fig. 1) . In total, 2020 and 1094 oocytes were isolated from 66 and 72 control and diabetic mice, respectively, for proteomic analysis.
Proteome profiling of mouse oocytes
The isobaric tags for relative and absolute quantitation (iTRAQ) method was used to quantify proteins expressed in control and diabetic mouse oocytes as previously described [11] . After high-performance liquid chromatography and mass spectrometry analyses, Proteome Discoverer (version 1.
3) was used to analyze the proteome data.
Western blotting
All antibodies used for western blot validation were purchased from Proteintech. The primary antibodies used were rabbit anti-HIST1H3D (20532-1-AP, 1:500), rabbit anti-NNT (13442-2-AP, 1:500), rabbit anti-PGK2 (13686-1-AP, 1:1000), rabbit anti-HIST2H2AA4 (15302-1-AP, 1:500), rabbit anti-GSS (15712-1-AP, 1:500), and mouse anti-GAPDH (60004-1-Ig, 1:10,000). Secondary antibodies were peroxidase-conjugated Affinipure goat anti-mouse IgG (H+L) (SA00001-1, 1:5000) and peroxidase-conjugated Affinipure goat antirabbit IgG(H+L) (SA00001-2, 1:5000). The total proteins from the two groups of oocytes were separated by SDS-PAGE and then transferred to polyvinylidene fluoride membranes. Subsequently, the membranes were washed, blocked, and incubated with the primary antibodies for 2 h at 25°C. The membranes were washed three times, incubated with the respective secondary antibody, and washed another three times. Western blots were visualized using enhanced chemiluminescence reagents (Santa Cruz Biotech). ImageJ was used for semi-quantification of protein levels.
Proteome data analysis
To identify differentially expressed proteins (DEPs) in diabetic oocytes, we calculated the log2 ratio of protein content in diabetic and normal oocytes (log2(STZ/Normal)). Values of log2(STZ/Normal) > 0.4 or < 0.04 in diabetic oocytes were considered to indicate up-or down-regulated proteins, respectively. To visualize the effects of DEPs on oocyte metabolic processes, we combined protein-protein interaction data from Reactome [12] and metabolism data from Biowarehouse [13] , and we visualized DEPs using Cytoscape [14] . Gene location data were obtained from the UCSC Genome Bioinformatics website (http://genome. ucsc.edu/). All scripts used for data analysis are available on request.
Spindle and chromosome staining in oocytes
For spindle and chromosome analysis, 54 oocytes from diabetic mice and 58 oocytes from control mice were collected and fixed in 4% paraformaldehyde in PBS for 30 min, and then permeabilized in 0.5% Triton X-100 at room temperature for 20 min. Next, the oocytes were blocked in 1% bovine serum albumin in PBS for 1 h, followed by incubation for 2 h at room temperature with fluorescein isothiocyanateconjugated β-tubulin antibody (1:300) to visualize the microtubules in the spindles. After washing three times in PBS containing 1% Tween-20 and 0.01% Triton X-100, the oocytes were stained with 10 µg/mL propidium iodide for 10 min. Finally, the oocytes were mounted on glass slides and viewed under a confocal laser scanning microscope (Zeiss LSM 710).
Immunofluorescence analysis of mitochondria
For staining of the mitochondrial and inner mitochondrial membrane potential, 53 oocytes from the control group and 50 oocytes from the diabetic group were cultured in M2 medium containing 200 nM Mito-Tracker Red for 30 min at 37°C in a 5% CO2 atmosphere. After staining was complete, the solution was replaced with fresh M2 medium, and oocytes were stained with 10 µg/mL Hoechst 33342 for 10 min. Finally, oocytes were mounted on glass slides and viewed under a confocal laser scanning microscope (Zeiss LSM 780).
Statistical analysis
Fisher's exact test was used to determine the statistical significance of differences between normal and diabetic oocytes, with p < 0.01 considered as indicative of statistical significance.
Results
Proteins differentially expressed between diabetic and normal oocytes
Using proteomic profiling, we identified 3521 proteins in diabetic and control mouse oocytes (for online supplementary material, see www.karger.com/doi/10.1159/000447924), of which 82 were downregulated and 70 were upregulated in oocytes from diabetic mice (see supplementary material). Five DEPs were selected (PGK2, HIST2H2AA4, GSS, NNT, and HIST1H3A) for western blot analysis to validate the proteome profiling results. Protein expression patterns evaluated by western blotting were consistent with the proteomics results (Fig. 2, Fig. 3 ), indicating the accuracy and reliability of the proteomic data.
To analyze the cellular localization of the DEPs and their associated biological processes, we annotated the DEPs using Gene Ontology terms (Tables 1 and 2 ). Type I diabetes mainly caused upregulation of proteins located in endoplasmic reticulum (ER) and mitochondria; however, downregulated proteins were primarily extracellular (Table 1 ). In addition, we found that type I diabetes principally influenced oocyte biological processes including transport, oxidation-reduction, lipid metabolism, metabolic processes, nucleosome assembly, proteolysis, and transcription ( Table 2) .
Effects of diabetes on mouse oocyte metabolism
In oocytes, mitochondria function in both energy production and maintenance of redox and Ca2+ homeostasis [15] . Redox status, which determines the level of reactive oxygen species (ROS) in cells, is regulated by three redox couples: reduced and oxidized glutathione (GSH), NADH/NAD+, and NADPH/NADP+ [16] . To determine how type I diabetes influences the various facets of metabolism, we assessed the differentially expressed metabolic enzymes FDXR, NNT, CYB5R3, HSD3B1, and PARP12. FDXR promotes mitochondrial NADPH production in diabetic oocytes (Fig. 4) and may therefore influence metabolite dynamics in diabetic oocyte mitochondria. NNT plays an essential role in proton transfer from NADPH to NAD+ to (H1.4), and HIST1H1D (H1.3)], whereas the other two were the H2A variant H2AFY (H2A.1) and the H3 variant HIST1H3A (H3.1). The three downregulated histone variants were variants of histone H2A: HIST2H2AB (H2A type 2-B), HIST3H2BA (H2B type 3-A), and HIS-T1H2AH (H2A type 1-H). In addition, TOP1 and HIST1H4A (histone H4) were upregulated in diabetic mouse oocytes. As most histone protein-coding regions cluster together in the mouse genome [19] , we analyzed the genomic localizations of these histone variants. We found that HIST1H1B, HIST1H2AH, HIST1H1D, HIST1H1E, HIST1H3A, HIST1H1C, and HIS-T1H1A clustered on murine chromosome 13 ( Table 3) .
Effects of maternal diabetes on microtubule assembly and chromosome alignment during oocyte maturation
We further probed the function of proteins associated with chromatin assembly and DNA packaging, such as linker histones that can affect chromatin remodeling activity. Con- focal scanning revealed a typical barrel-shaped spindle and well-aligned chromosomes on the metaphase plate in control MII oocytes (normal rate: 91.4%, N = 58). In contrast, a significantly elevated number of diverse malformed spindles was observed in ovulated MII oocytes from diabetic mice (normal rate: 61.1%; N = 54; p < 0.01). The rate of chromosome misalignment was also significantly increased in oocytes from diabetic mice, as characterized by the displacement of chromosomes from the equator (Fig. 5A ). These results suggest that maternal diabetes induces spindle defects and causes abnormal chromosome alignment in oocyte meiosis via modulation of protein expression.
Effects of maternal diabetes on the spatial remodeling of mitochondria during oocyte maturation
To further determine the function of key proteins associated with mitochondrial metabolism, such as FDXR and NNT, MII oocytes were collected from control and diabetic mice to determine the mitochondrial localization and for visualization of chromosomes. Mitochondrial distribution patterns were evaluated using fluorescence microscopy. Among control oocytes, 75.5% (N = 53) possessed normal mitochondria; however, only 36.0% (N = 50) of diabetic oocytes had normal mitochondria (p < 0.01). When compared with the control group, the diabetic group was found to have a reduced overall number of mitochondria, and the mitochondrial distribution was heterogeneous (Fig. 5B) . Our results suggest that maternal diabetes causes abnormal mitochondrial distribution during oocyte maturation as a result of altered protein expression.
Discussion
Understanding how type I diabetes affects the oocyte proteome, and therefore female reproduction and embryonic development, may facilitate the identification of novel treatments and preventative measures for this disease or innovative ways to assist reproduction in affected women. Type I diabetes induces ROS accumulation and subsequently triggers cell dysfunction [20] . Insulin resistance is thus likely to increase ROS levels in oocytes [21] . Our results revealed downregulation of GSS in diabetic oocytes, which is expected to lead to decreased production of GSH. In contrast, increased levels of mitochondrial proteins are predicted to result in increased ROS production; hence, oxidative stress is a critical factor in the metabolism of diabetic oocytes. Previous reports have shown that glycolysis is blocked during oocyte maturation and early embryo development [22] . Moreover, production of NADPH is not affected by the pentose phosphate pathway in unfertilized oocytes [23] . In addition, lactate and pyruvate can respectively increase and decrease NAD(P)H levels [23] . NADPH is a substrate for GSH production and essential for controlling ROS levels in oocytes. Further research is needed to explore whether or not lactate supplementation and decreasing pyruvate levels could control ROS levels, leading to a reduction of oxidative stress in diabetic oocytes. Emodin is one of the major components of Rheum palmatum. It could effect on high glucose induced-podocyte mesenchymal transition by reducing oxidative stress which give us a potential clue to against free radical damage in diabetic oocytes [24] .
At present, more and more people pay attention to the relationship between diabetes and epigenetics (DNA methylation, noncoding RNAs, nucleosome remodeling and histone modifications). We hypothesized that the phenotype transmission from parents to offspring is associated with the change of histone modification in oocytes of maternal diabetes.
The linker histone H1 has multiple effects on chromatin. Linker histones are critical for chromatin compaction and control nucleosome repeat length [25] . Furthermore, linker histones can alter the chromatin remodeling activity of ATP-dependent chromatin remodeling enzymes [26] and typically inhibit gene expression; however, they can also specifically activate the expression of certain genes [27] . In Xenopus laevis oocytes, histone H1 variant B4 participates in sperm chromatin remodeling [28] , and similar functions have been observed for its mammalian homologue, H1foo [29] . In the present study, we identified five linker H1 histone variants that were upregulated in diabetic oocytes and may thus influence chromatin structure in these cells. Alterations in the expression of these maternal linker histones could also affect the development of early embryos. Recently, Shinagawa et al [30] . showed that histone variants enriched in oocytes are essential for reprogramming of early embryonic blastomeres, and that HIST1H2AA and HIST1H2BA are associated with paternal genome activation in zygotes. Therefore, the downregulation of histone H2 variants in diabetic oocytes observed in the present study could impair the activation of the zygotic genome. Additionally, a core histone H2 variant, H2AFY, was upregulated in diabetic oocytes. H2AFY prevents genome reprogramming, and its absence is required for early embryonic development [31] . Thus, the observed upregulation of H2AFY in diabetic oocytes may be predicted to impair embryonic development. Histone H3.3 is essential for oocyte and zygote reprogramming and for rRNA transcription in zygotes [32] ; however, HIST1H3A is expressed at very low levels in MII oocytes and in the early embryonic stages. HIST1H3A does not incorporate into chromatin when it is present at low levels [33] ; hence, the significant upregulation of HIST1H3A in diabetic oocytes observed in the present study may also impair zygotic genome reprogramming.
During gestation, metabolic needs significantly increases. Failure of meeting these requirements may result in GDM [34] , Diabetes affect the ovulation maybe by hypothalamicpituitary axis. This study demonstrates changes in metabolic processes and histone variants in diabetic oocytes, leading to impaired oocyte quality and early embryonic development. Therefore, when oocytes from women with diabetes are used for assisted reproduction, methods to reduce ROS levels and expression of histone variants should be considered. In addition, the proteins identified in this study may serve as markers whose expression could be evaluated in the first or second polar bodies for assessment of oocyte quality.
In summary, these results illustrate potential targets and methods for improving diabetic oocyte quality and preventing subfertility in women with type I diabetes undergoing assisted reproduction. These results characterize the effects of diabetes on reproduction in an animal model, and further studies in humans are warranted.
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